Singapore to India: Reagent Import Trade Route
India has recorded 26 verified shipments of Reagent imported from Singapore, representing a combined trade value of $72.5K USD. This corridor is served by 6 active Singapore exporters, with an average shipment value of $2.8K USD. The leading Singapore supplier is SYSMEX ASIA PACIFIC PTE LTD, which accounts for 54% of total import value with 8 shipments worth $39.2K USD. On the buying side, SYSMEX INDIA PRIVATE LIMITED is the largest Indian importer with $39.2K USD in purchases. The top 3 suppliers — SYSMEX ASIA PACIFIC PTE LTD, LIFE TECHNOLOGIES HOLDINGS PTE LTD , MILTENYI BIOTEC ASIA PACIFIC PTE LTD — together control 95% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.

Route Intelligence Overview
The Singapore to India Reagent corridor is one of India's established pharmaceutical import routes from Singapore, with 26 shipments documented worth a combined $72.5K USD. The route is dominated by SYSMEX ASIA PACIFIC PTE LTD, which alone accounts for roughly 54% of all import value, reflecting the consolidated nature of Singapore's reagent export sector.
Across 6 active Singapore suppliers, the average shipment value stands at $2.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with reagent's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 29.1%, placing it at rank #15 among India's top reagent import origins globally.
On the Indian buyer side, key Indian importers include SYSMEX INDIA PRIVATE LIMITED, INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED , CYTOCARE TECHNOLOGIES PRIVATE LIMITED and 4 others. SYSMEX INDIA PRIVATE LIMITED is the single largest Indian importer with 8 shipments valued at $39.2K USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ3
- Primary modeSea freight
- Top port of entryBANGALORE ACC (INBLR4)
Market Position
- Global rank#15
- Annual growth+29.1%
- Demand growth+26.2%
- Regulatory ease80/100
Top 10 Reagent Exporters from Singapore to India
Showing top 10 of 6 Singapore suppliers exporting Reagent to India, ranked by total trade value (USD)
| Rank | Supplier (Singapore Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SYSMEX ASIA PACIFIC PTE LTD Avg $4.9K per shipment | 8 | $39.2K | 54.1% |
| 2 | LIFE TECHNOLOGIES HOLDINGS PTE LTD Avg $3.7K per shipment | 6 | $22.1K | 30.5% |
| 3 | MILTENYI BIOTEC ASIA PACIFIC PTE LTD Avg $3.7K per shipment | 2 | $7.5K | 10.3% |
| 4 | MILTENYI BIOTEC ASIA PACIFIC PTE LTD Avg $1.9K per shipment | 1 | $1.9K | 2.6% |
| 5 | BECTON DICKINSON HOLDINGS PTE LTD Avg $1.5K per shipment | 1 | $1.5K | 2.0% |
| 6 | LIFE TECHNOLOGIES HOLDINGS PTE LTD Avg $37 per shipment | 8 | $294 | 0.4% |
This table shows the top 10 of 6 Singapore companies exporting reagent to India, ranked by total trade value. The listed exporters are: SYSMEX ASIA PACIFIC PTE LTD, LIFE TECHNOLOGIES HOLDINGS PTE LTD , MILTENYI BIOTEC ASIA PACIFIC PTE LTD, MILTENYI BIOTEC ASIA PACIFIC PTE LTD , BECTON DICKINSON HOLDINGS PTE LTD, LIFE TECHNOLOGIES HOLDINGS PTE LTD. SYSMEX ASIA PACIFIC PTE LTD is the dominant supplier with 8 shipments worth $39.2K USD, giving it a 54% market share. The top 3 suppliers together account for 95% of the total trade value on this route.
Top 10 Indian Reagent Importers from Singapore
Showing top 10 of 7 known Indian buyers receiving Reagent shipments from Singapore, ranked by import value
On the receiving end of this trade route, the leading Indian importers of Singapore reagent include SYSMEX INDIA PRIVATE LIMITED, INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED , CYTOCARE TECHNOLOGIES PRIVATE LIMITED, AURIGENE ONCOLOGY LIMITED, CYTOCARE TECHNOLOGIES PRIVATE LIMITED , among 7 total buyers. The largest importer is SYSMEX INDIA PRIVATE LIMITED, accounting for $39.2K USD across 8 shipments — representing 54% of all reagent imports from Singapore on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SYSMEX INDIA PRIVATE LIMITED | 8 | $39.2K | 54.1% |
| 2 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | 6 | $22.1K | 30.5% |
| 3 | CYTOCARE TECHNOLOGIES PRIVATE LIMITED | 1 | $4.1K | 5.7% |
| 4 | AURIGENE ONCOLOGY LIMITED | 1 | $3.4K | 4.7% |
| 5 | CYTOCARE TECHNOLOGIES PRIVATE LIMITED | 1 | $1.9K | 2.6% |
| 6 | NARAYANA NETRALAYA FOUNDATION | 1 | $1.5K | 2.0% |
| 7 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | 8 | $294 | 0.4% |
Top 10 Reagent Formulations Imported from Singapore
Showing top 10 of 19 product formulations shipped on the Singapore to India Reagent route, ranked by trade value
India imports a wide range of reagent formulations from Singapore, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Dade Fibrinogen Determination Reagents Batch :03159 ITEM NO:B423315SYDade Fibrinogen Determination Reagents Batch :03159 ITEM N — accounts for $30.6K USD across 1 shipments. There are 19 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Dade Fibrinogen Determination Reagents Batch :03159 ITEM NO:B423315SYDade Fibrinogen Determination Reagents Batch :03159 ITEM N | 1 | $30.6K | 42.3% |
| 2 | 338500 MOUSE ANTI-CYTOCHROME C (CLONE 200 UG (DIAGNOSTIC REAGENTS BASED ON A) | 2 | $20.4K | 28.1% |
| 3 | Dade Fibrinogen Determination Reagents 6 X 1ML Batch : 03159ITEM NO : B423315SY - (Fibrinogen LIST 4 SL NO 34)(ImmunoDade Fibrinogen Determination Reagents 6 X 1ML Batch : 03159 | 1 | $7.6K | 10.4% |
| 4 | 200-070-113 273-01 BATCH 6230500025 CLINIMACS CD3 REAGENT CE-MARKED 1 VIAL 7,5 ML STORAGE AT 2-8C | 1 | $4.1K | 5.7% |
| 5 | 130-127-342 BATCH5250309671 CD19 CAR DETECTION REAGENT (A-FMC63) ANTIBODY, ANTI-HUMAN, PE, REAFINITY#, CLONE REA1297,30130-127-342 BATCH5250309671 CD19 CAR DETECTION REAGENT (A-FM | 1 | $3.4K | 4.7% |
| 6 | 200-070-146 701-46 BATCH 6220700044 CLINIMACS CD45RA REAGENTSTORAGE AT 2-8 C | 1 | $1.9K | 2.6% |
| 7 | 558355 HU IL-3 CBA FLEX SET D5 100 TST (FOR RESEARCH PURPOSE)558355 HU IL-3 CBA FLEX SET D5 100 TST (LAB REAGENT FOR RESE | 1 | $1.5K | 2.0% |
| 8 | 368800 50 UG PHOSPHO-ERK1/ERK2 (THR202, TYR (DIAGNOSTIC REAGENTS BASED ON A) | 3 | $1.0K | 1.4% |
| 9 | MA514505 ANTI-PROGESTERONE RECEPTOR EA (DIAGNOSTIC REAGENTSBASED ON A) INR | 1 | $704 | 1.0% |
| 10 | DIAGNOSTIC REAGENTS -CRP FS BATCH:37159ITEM NO: ZPS13211 DIAGNOSTIC REAGENTS | 1 | $265 | 0.4% |
Showing top 10 of 19 Reagent formulations imported from Singapore on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 77%, typical for bulk pharmaceutical shipments.
Top Indian Ports of Entry
BANGALORE ACC (INBLR4) handles the highest volume with 16 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's reagent imports from Singapore are driven primarily by a handful of large-scale Singapore manufacturers. SYSMEX ASIA PACIFIC PTE LTD with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — Indian buyers benefit from Singapore supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SYSMEX ASIA PACIFIC PTE LTD, LIFE TECHNOLOGIES HOLDINGS PTE LTD , MILTENYI BIOTEC ASIA PACIFIC PTE LTD — together account for 95% of total trade value on this route. The average shipment value of $2.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as 338500 mouse anti-cytochrome c (clone 200 ug (diagnostic reagents based on a) and dade fibrinogen determination reagents 6 x 1ml batch : 03159item no : b423315sy - (fibrinogen list 4 sl no 34)(immunodade fibrinogen determination reagents 6 x 1ml batch : 03159, suggesting that Indian buyers tend to consolidate orders across related product lines from the same Singapore supplier.
On the buying side, SYSMEX INDIA PRIVATE LIMITED is the largest importer with 8 shipments worth $39.2K USD — representing 54% of all reagent imports from Singapore on this route. A total of 7 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $72.5K
- Avg. Shipment
- $2.8K
- Suppliers
- 6
- Buyers
- 7
- Transit (Sea)
- ~20 days
- Annual Growth
- +29.1%
Unlock the Full Singapore to India Reagent Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 26 shipments on this route.
Frequently Asked Questions — Singapore to India Reagent Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Singapore companies export Reagent to India?
The leading Singapore exporters of Reagent to India are SYSMEX ASIA PACIFIC PTE LTD, LIFE TECHNOLOGIES HOLDINGS PTE LTD , MILTENYI BIOTEC ASIA PACIFIC PTE LTD. SYSMEX ASIA PACIFIC PTE LTD holds the largest market share at approximately 54% of total trade value on this route.
Q What is the total value of Reagent imports from Singapore to India?
India imports Reagent from Singapore worth approximately $72.5K USD across 26 recorded shipments. The average value per shipment is $2.8K USD.
Q Which Indian ports receive Reagent from Singapore?
The most active Indian port of entry is BANGALORE ACC (INBLR4) with 16 shipments. Singapore exporters primarily use sea freight for this route, with 77% of shipments going by sea and 24% by air.
Q How long does shipping take from Singapore to India for Reagent?
The average transit time for Reagent shipments from Singapore to India is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the Singapore to India Reagent import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 29.1% with demand growth tracking at 26.2%. The route is ranked #15 among India's top Reagent import origins globally.
Q How many Singapore suppliers are active on this Reagent import route?
There are currently 6 active Singapore suppliers exporting Reagent to India. The market is moderately concentrated with SYSMEX ASIA PACIFIC PTE LTD accounting for 54% of total shipment value.
Q Who are the main Indian importers of Reagent from Singapore?
The leading Indian importers of Reagent from Singapore include SYSMEX INDIA PRIVATE LIMITED, INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED , CYTOCARE TECHNOLOGIES PRIVATE LIMITED, AURIGENE ONCOLOGY LIMITED, CYTOCARE TECHNOLOGIES PRIVATE LIMITED . SYSMEX INDIA PRIVATE LIMITED is the largest buyer with 8 shipments worth $39.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Singapore export trade corridor identified from Indian Customs (DGFT) records for Reagent.
- 2.Supplier/Buyer Matching: 6 Indian exporters and 7 importers in Singapore matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 26 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
26 Verified Shipments
6 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists